XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Shares Reserved for Future Issuance
The Company has reserved shares of common stock for future issuances as follows:
June 30,December 31,
20242023
Common stock options issued and outstanding3,766,402 3,142,981 
Common stock restricted stock units issued and outstanding3,197,736 2,244,903 
Common stock available for future grants2,951,051 2,541,438 
Common stock available for employee stock purchase plan1,731,920 1,436,823 
Total11,647,109 9,366,145 
Schedule of Summary of Stock Option Activity
A summary of stock option activity for the existing stock plans and the inducement awards for the six months ended June 30, 2024 is set forth below:
Outstanding Options
Number of SharesWeighted Average Exercise Price
Balance, January 1, 2024
3,142,981 $16.40 
Options granted
895,125 9.09 
Options exercised
(39,466)2.02 
Options canceled
(232,238)21.85 
Balance, June 30, 20243,766,402 $14.48 
Schedule of Options Vested and Expected to Vest
The aggregate intrinsic value of options outstanding as of June 30, 2024 was $3.7 million.
June 30, 2024
Number of Shares
Weighted Average Exercise Price
Weighted Average Contractual Life (in Years)
Options vested and exercisable1,954,036$15.32 6.45
Options vested and expected to vest3,766,402$14.48 7.64
Schedule of Activity with Respect to Restricted Stock Units
A summary of restricted stock units activity for the existing stock plans and the inducement awards for the six months ended June 30, 2024 is set forth below:
Number of Shares Underlying Outstanding Restricted StockWeighted Average Grant Date Fair Value
Unvested, January 1, 20242,244,903 $15.74 
Granted1,705,208 8.89 
Vested
(505,946)16.10 
Canceled
(246,429)14.75 
Unvested, June 30, 20243,197,736 $12.11 
Schedule of Total Stock-Based Compensation
Stock-based compensation expense is reflected in the statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Cost of goods sold$435 $391 $816 $614 
Research and development714 760 1,487 1,326 
Selling, general and administrative4,771 4,711 9,290 8,560 
Total$5,920 $5,862 $11,593 $10,500 
The above stock-based compensation expense related to the following equity-based awards (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Stock options and restricted stock units$5,818 $5,799 $11,299 $10,339 
Employee stock purchase plan102 63 294 161 
Total$5,920 $5,862 $11,593 $10,500